Draft:Bramble Bio
Submission declined on 30 March 2026 by Robert McClenon (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: This draft is written from the viewpoint of the company, focusing on what the company says about itself. Corporate notability is based on what independent reliable sources have written about the subject.Not every business corporation is notable, and this draft does not establish corporate notability. You may ask for advice about corporate notability at the Teahouse. Robert McClenon (talk) 16:04, 30 March 2026 (UTC)
Bramble Bio is a contract development and manufacturing organisation (CDMO) specializing in cell therapy and gene therapy products. It provides end-to-end services for advanced therapy medicinal products (ATMPs) and advanced therapeutic investigational medicinal products (ATIMPs), including process development, optimization, technology transfer, current Good Manufacturing Practice (cGMP) manufacturing, analytical testing, cell and tissue sourcing, regulatory guidance, and global logistics.
History
The organisation originated as FamiCord Cell & Gene Manufacturing, part of the FamiCord Group, a European stem cell banking and biotechnology network founded in 2002. The Warsaw-based CDMO expanded services in the 2010s to include GMP-compliant manufacturing of cell therapies for clinical use. In January 2025, FamiCord Cell & Gene Manufacturing rebranded as Bramble Bio to reflect a broadened mission in advancing cell and gene therapy innovation and to emphasize its interconnected global network of facilities and partners.
Operations
Bramble Bio operates facilities in Warsaw, Poland, and Cantanhede, Portugal, with a network of laboratories and cryopreservation sites across Europe, the Middle East, and Asia. It has supported the development, manufacture, and distribution of ATMPs for clinical trials in a broad range of indications, contributing to therapies administered to thousands of patients worldwide.
Services
The company’s core activities include:
- Process development and optimization for cellular products.
- Tech transfer and cGMP manufacturing of autologous and allogeneic cell therapies.
- Analytical method development and testing, including potency assays.
- Primary cell and tissue sourcing particularly from perinatal tissues
- Regulatory and quality guidance to support compliance with international standards.
- Logistics and cold-chain management for sensitive biological materials.
Partnerships
Bramble Bio collaborates with biotech companies and research organisations to manufacture and scale advanced therapies, exemplified by strategic partnerships for production of treatments for diseases such as Duchenne muscular dystrophy and acute kidney injury.
Headquarters
The company’s headquarters is located in Warsaw, Poland, with an additional operational facility in Cantanhede, Portugal.
References
https://www.ema.europa.eu/en/news/new-guidelines-good-manufacturing-practices-advanced-therapies
https://eur-lex.europa.eu/eli/reg/2007/1394/oj/eng
External links
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
- provide significant coverage: discuss the subject in detail, excluding routine coverage like product launches, staff appointments, or financial reports and listings in databases or listicles;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as press releases, the subject's own website, or sponsored content.
Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia.